RxDoctor Payments Data

Jackquelyn Williams, NP

Psychiatric/Mental Health · Burleson, TXNPI 1306249602

Payments from drug & device makers

$2,480in general payments, 2019–2025

Across 80 payments — averaging $31.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceutical Holding Company Ltd.$965
  • AbbVie$227
  • Amgen$172
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$144
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$138
  • Scilex Pharmaceuticals Inc.$111
  • plus $723 from 20 others

What the payments were for

  • Consulting fees$80032%
  • Food & beverage$1,68068%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,480 in reported general payments places this provider in the 75th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$16,291
Medicare patients
45
Services billed
171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,512
Buspirone Hcl31$469
Venlafaxine Hcl ErVenlafaxine Hcl17$432
Duloxetine Hcl23$410
Aripiprazole15$394
Quetiapine Fumarate14$314
Trazodone Hcl27$276
Clonazepam29$184
Sertraline Hcl13$157
Lamotrigine18$112
Fluoxetine Hcl19$96
Escitalopram Oxalate11$81
Alprazolam17$66

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Burleson

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →